Lipid peroxidation and cyclooxygenase enzyme inhibitory activities of acidic aqueous extracts of some dietary supplements

Phytotherapy Research

Volumn 22, Issue 2, 2008, Pages 204-212

  Raman, Priyadarshini ^a   DeWitt, David L ^b   Nair, Muraleedharan G ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b Michigan State University   (United States)

Author keywords

Botanicals; COX; Dietary supplements; Lipid peroxidation

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; ELEUTHEROCOCCUS SENTICOSUS EXTRACT; GARLIC EXTRACT; GINKGO BILOBA EXTRACT; GINSENG EXTRACT; GRAPE SEED EXTRACT; HYPERICUM PERFORATUM EXTRACT; KAVA EXTRACT; SABAL EXTRACT; WATER;

AQUEOUS SOLUTION; ARTICLE; DIET SUPPLEMENTATION; DRUG ISOLATION; DRUG SELECTIVITY; ENZYME INHIBITION; IN VITRO STUDY; INHIBITION KINETICS; LIPID PEROXIDATION; PH; SIMULATION; STOMACH; TEMPERATURE;

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE INHIBITORS; DIETARY SUPPLEMENTS; ECHINACEA; GARLIC; GINKGO BILOBA; HYDROGEN-ION CONCENTRATION; KAVA; LIPID PEROXIDATION; PANAX; PLANT EXTRACTS;

ALLIUM SATIVUM; ELEUTHEROCOCCUS SENTICOSUS; PANAX GINSENG; PIPER METHYSTICUM; SERENOA REPENS; VITACEAE;

EID: 40549139151     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2287     Document Type: Article

References (48)

1. Adderley SR, Fitzgerald DJ. 1999. Oxidative damage of cardiomyocytes is limited by extracellular regulated kinases 1/2-mediated induction of cyclooxygenase-2. J Biol Chem 274: 5038-5046.
2. Arora A, Nair MG, Strasburg GM. 1998. Structure-activity relationships for antioxidant activities of a series of flavonoids in a liposomal system. Free Radic Biol Med 24: 1355-1363.
3. Arora A, Strasburg GM. 1997. Development and validation of fluorescence spectroscopic assays to evaluate antioxidant efficacy. Application to metal chelators. J Am Oil Chem Soc 74: 1031-1040.
4. Bagchi D, Garg A, Krohn RL et al. 1998. Protective effects of grape seed proanthocyanidins and selected antioxidants against TPA-induced hepatic and brain lipid peroxidation and DNA fragmentation, and peritoneal macrophage activation in mice. Gen Pharmacol 30: 771-776.
5. Baker CS, Hall RJ, Evans TJ. 1999. Cyclooxygenase-2 is widely expressed in atherosclerotic lesions affecting native and transplanted human coronary arteries and colocalizes with inducible nitric oxide synthase and nitrotyrosine particularly in macrophages. Arterioscler Thromb Vasc Biol 19: 646-655.
6. Blumenthal M. 1999. Herbal market levels after five years of boom. HerbalGram 47: 64-65.
7. Bors W, Saran M. 1987. Radical scavenging by flavonoid antioxidants. Free Radic Res Commun 2: 289-294.
8. Cabral de Oliveira, Antonio C, Perez AC, Merino G, Preito JG, Alvarez AI. 2001. Protective effects of Panax ginseng on muscle injury and inflammation after eccentric exercise. Comp Biochem Physiol 130C: 369-377.
9. Cryer B, Dubois A. 1998. The advent of highly selective inhibitors of cyclooxygenase - a review. Prostaglandins Other Lipid Mediators 56: 341-361.
10. Dannenberg AJ, Subbaramaiah, K. 2003. Targetting cyclo-oxygenase-2 in human neoplasia: rationale and promise. Cancer Cell 4: 431-136.
11. Dressman JB, Berardi RR, Dermentzoglou LC et al. 1990. Upper gastrointestinal (GI) pH in young, healthy men and women. Pharm Res 7: 756-761.
12. Eisenberg DM, Davis RB, Ettner SL et al. 1998. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA 280: 1569-1575.
13. Escher M, Desmeulus J, Giostra E, Mentha G. 2001. Hepatitis associated with kava, a herbal remedy for anxiety. Br Med J 322: 139.
14. Facino RM, Carini M, Aldini G, Saibene L, Pietta P, Mauri P. 1995. Echinosides and caffeoyl conjugates protect collagen from free radical-induced degradation: A potential use of Echinacea extracts in the prevention of skin photodamage. Planta Med 61: 510-514.
15. Francis JA, Jayaprakasam B, Olson LK, Nair MG. 2004. Insulin secretagogues from Moringa oleifera with cyclooxygenase enzyme and lipid peroxidation inhibitory activities. Helv Chim Acta 87: 317-326.
16. Goldman WH, Sharma AL, Currier SJ, Johnston PD, Ajay R, Pal Sharma C. 2001. Saw palmetto berry extract inhibits cell growth and Cox-2 expression in prostatic cancer cells. Cell Biol Int 25: 1117-1124.
17. Herendeen JM, Lindley C. 2003. Use of NSAIDs for the chemoprevention of colorectal cancer. Ann Pharmacother 37: 1664-1674.
18. Hsi LC, Angerman-Stewart J, Eling TE. 1999. Introduction of full-length APC modulates cyclooxygenase-2 expression in HT-29 human colorectal carcinoma cells at the translational level. Carcinogenesis 20: 2045-2049.
19. Hu C, Kitts DD. 2000. Studies on the antioxidant activity of Echinacea root extract. J Agric Food Chem 48: 1466-1472.
20. Humberston CL, Akhtar J, Krenzelok EP. 2003. Acute hepatitis induced by kava kava. J Toxicol Clin Toxicol 41: 109-113.
21. Juni P, Nartey L, Reichenback S, Sterchi R, Dieppe PA, Egger M. 2004. Risk of cardiovascular events and rofecoxib: cumulative meta-analysis. Lancet 364: 2021-2029.
22. Kanowski S, Hoerr R. 2003. Ginkgo biloba extract EGb 761 in dementia: intent-to-treat analyses of a 24-week, multi-center. double-blind, placebo-controlled, randomized trial. Pharmacopsychiatry 36: 297-303.
23. Kasper S, Anghelescu IG, Szegedi A, Dienel A, Kieser M. 2006. Superior efficacy of St. John's Wort extract WS 5570 compared to placebo in patients with major depression: a randomized, double-blind, placebo-controlled, multi-center trial. BMC Med 4: 14.
24. Kate J, Cheng KK, Langman MJS. 2002. NSAIDs and gastrointestinal cancer prevention. Drugs 62: 945-956.
25. Kolodziej H, Haberland C, Woerdenbag HJ, Konings AWT. 1995. Moderate cytotoxicity of proanthocyanidins to human tumor cell lines. Phytother Res 9: 410-415.
26. Lau BHS. 2001. Suppression of LDL oxidation by garlic. J Nutr 131: 985S-988S.
27. Lehrl S. 2004. Clinical efficacy of kava extract WS1490 in sleep disturbances associated with anxiety disorders. Results of a multicenter, randomized, placebo-controlled, double-blind clinical trial. J Affect Disord 78: 101-110.
28. Lipisky PE. 1999. The clinical potential of cyclooxygenase-2-specific inhibitors. Am J Med 106: 51S-57S.
29. Luk GD. 1996. Prevention of gastrointestinal cancer-the potential role of NSAIDs in colorectal cancer. Schweiz Med Wochenschr 126: 801-812.
30. Malagelada JR, Longstreth GF, Summerskill WH, Go VL. 1976. Measurement of gastric functions during digestion of ordinary solid meals in man. Gastroenterology 70: 203-210.
31. Malagelada JR, Longstreth GF, Deering TB, Summerskill WH, Go VL. 1977. Gastric secretion and emptying after ordinary meals in duodenal ulcer. Gastroenterology 73: 989-994.
32. Mukherjee D, Nissen SE, Topol EJ. 2001. Risk of cardiovascular events associated with selective COX-2 inhibitors. JAMA 286: 954-959.
33. Muller-Jakic B, Breu W, Probstle A, Redl K, Greger H, Bauer R. 1994. In vitro inhibition of cyclooxygenase and 5-lipoxygenase by alkamides from Echinacea and Achillea species. Planta Med 60: 37-40.
34. Pietri S, Maurelli E, Drieu K, Culcasi M. 1997. Cardioprotective and anti-oxidant effects of the terpenoid constituents of Ginkgo biloba extract (Egb 761). J Mol Cell Cardiol 29: 733-742.
35. Ricardo da Silva JM, Darmon N, Fernandez Y, Mitjavila S. 1991. Oxygen free radical scavenging capacity in aqueous models of different procyanidins from grape seeds. J Agric Food Chem 39: 1549-1552.
36. Schonbeck U, Sukhova GK, Graber P, Coulter S, Libby P. 1999. Augmented expression of cyclooxygenase-2 in human atherosclerotic lesions. Am J Pathol 155: 1281-1291.
37. Seeram NP, Momin RA, Nair MG, Bourquin LD. 2001. Cyclo-oxygenase inhibitory and antioxidant cyanidin glycosides in cherries and berries. Phytomedicine 8: 362-369.
38. Shen J, Zhao B, Li M, Wan Q, Wen-Jian. 1996. Inhibitory effects of Ginkgo biloba extract (Egb 761) on oxygen free radicals, nitric oxide and myocardial injury in isolated ischemic-reperfused hearts. In Proceedings of the International Symposium on Natural Antioxidants. Molecular mechanisms and Health Effects. AOCS Press, Champaign, Illinois, USA, 453-465.
39. Singh YN, Devkota AK. 2003. Aqueous kava extracts do not affect liver function tests in rats. Planta Med 69: 496-499.
40. Slattery ML, Samowitz W, Hoffmann M, Ma KN, Levin TR, Neuhausen S. 2004. Aspirin, NSAIDs, and colorectal cancer: possible involvement in an insulin-related pathway. Cancer Epidemiol Biomarkers Prev 13: 538-545.
41. Smith WL, DeWitt DL. 1996. Prostaglandin endoperoxide H synthases-1 and -2. Adv Immunol 62: 167-215.
42. Sorrentino L, Capasso A, Schmidt M. 2006. Safety of ethanolic kava extract: Results of a study of chronic toxicity in rats. Phytomedicine 13: 542-549.
43. Wang H, Nair MG, Strasburg GM, Booren AM, Gray I, Dewitt DL. 2000. Cyclooxygenase active bioflavonoids from Balaton™ tart cherry and their structure activity relationships. Phytomedicine 7: 15-19.
44. Watson AJM. 1998. Chemopreventive effects of NSAIDs against colorectal cancer: regulation of apoptosis and mitosis by COX-1 and COX-2. Histol Histopathol 13: 591-597.
45. Weber W, Taylor JA, Stoep AV, Weiss NS, Standish LJ, Calabrese C. 2005. Echinacea purpurea for prevention of upper respiratory tract infections in children. J Altern Complement Med 11: 1021-1026.
46. 2/NaOH/DMSO system. J Agric Food Chem 47: 2544-2548.
47. Yenilmez A, Kilic FS, Sirmagul B, Isikli B, Aral E, Oner S. 2007. Preventive effects of Ginkgo biloba extract on ischemia-reperfusion injury in rat bladder. Urol Int 78: 167-172.
48. Zarraga IG, Schwarz ER. 2007. Coxibs and heart disease: What we have learned and what else we need to know. J Am Coll Cardiol 49: 1-14.